Evidence map›Paper›PMID 40459293›Full record

ArticleApplied and environmental microbiology2025

Ming-Xuan Tang, Peng-Fei Meng, Ruo-Lin Huang, Xin Zheng, Chen-Chen Liang, Xuepiao Pu, Chen Wang, Ying Zhao, Yi-Qiu Zhang, Jia-Xin Liang and 9 more

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A programmableApplied and environmental microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ming-Xuan TangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID 0009-0007-1542-5027
Peng-Fei MengSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Ruo-Lin HuangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xin ZhengSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Chen-Chen LiangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xuepiao PuSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Chen WangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Ying ZhaoSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yi-Qiu ZhangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Jia-Xin LiangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yu-Xi YanSchool of Environmental Science and Engineering, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yanyu XiaoDepartment of Clinical Laboratory, Shenzhen Third People's Hospital, National Clinical Research Center for Infectious Diseases, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.
Ying AnSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xiaoye LiangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yi SongSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Jiuxin QuDepartment of Clinical Laboratory, Shenzhen Third People's Hospital, National Clinical Research Center for Infectious Diseases, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.
Bo YuDepartment of Microbial Physiological & Metabolic Engineering, State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0003-3148-0986
Yu XiaSchool of Environmental Science and Engineering, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Tao DongSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID 0000-0003-3557-1850

Funding

GDSTC | Guangdong Provincial Introduction of Innovative Research and Development Team (Guangdong Innovative Research Team Program) 2023ZT10Y013MOST | National Natural Science Foundation of China (NSFC) 32030001, W2431022MOST | National Natural Science Foundation of China (NSFC) 32400096MOST | National Natural Science Foundation of China (NSFC) W2433062
6 · The paper itself

Abstract

Recombinant protein production is crucial for biotechnology and industrial processes. While IMPORTANCE: AMAX complements current systems by addressing challenges such as phage contamination and high GC-content protein expression, while offering rapid growth, high protein yields, and adaptability to saline environments. Its favorable biosafety profile and potential for OMV-based protein delivery further enhance its application, making it a versatile platform for sustainable and efficient bioproduction.

Indexed as

AeromonasRecombinant ProteinsEscherichia coliRecombinant ProteinsOMVsprotein expressionresist phage infectiontranscriptome

Identifiers

PMID40459293
PMCPMC12285260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.